We are live on ! Find out more
CP

Corbenic Partners Portfolio holdings

AUM $380M
1-Year Est. Return 10.47%
This Fund
S&P 500
This Quarter Est. Return
+0.51%
1 Year Est. Return
-10.47%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$412M
AUM Growth
+$30.8M
Cap. Flow
+$30M
Cap. Flow %
7.28%
Top 10 Hldgs %
67.78%
Holding
312
New
49
Increased
64
Reduced
28
Closed
22

Top Buys

Rank Stock Value
1
DGRO icon
iShares Core Dividend Growth ETF
DGRO
+$5.61M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$4.92M
3
JMST icon
JPMorgan Ultra-Short Municipal Income ETF
JMST
+$3.82M
4
VIG icon
Vanguard Dividend Appreciation ETF
VIG
+$2.22M
5
VZ icon
Verizon
VZ
+$1M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$288K
2
MUB icon
iShares National Muni Bond ETF
MUB
+$166K
3
BABA icon
Alibaba
BABA
+$153K
4
GREK
Global X MSCI Greece ETF
GREK
+$85K
5
PG icon
Procter & Gamble
PG
+$27.8K

Sector Composition

Rank Sector Weight
1 Technology 11.17%
2 Consumer Discretionary 7.31%
3 Healthcare 5.06%
4 Communication Services 3.64%
5 Utilities 3.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHW icon
101
Sherwin-Williams
SHW
$78.4B
$29K 0.01%
105
– –
PLTK icon
102
Playtika
PLTK
$1.4B
$28K 0.01%
1,000
– –
VOO icon
103
Vanguard S&P 500 ETF
VOO
$967B
$28K 0.01%
70
– –
VIEW
104
DELISTED
View, Inc. Class A Common Stock
VIEW
$27K 0.01%
83
– –
MRNA icon
105
Moderna
MRNA
$21.6B
$25K 0.01%
+64
New +$23.6K
T icon
106
AT&T
T
$164B
$25K 0.01%
1,231
-526
-30% -$11.1K
BOWX
107
DELISTED
BowX Acquisition Corp. Class A Common Stock
BOWX
$25K 0.01%
2,475
– –
ASAN icon
108
Asana
ASAN
$1.57B
$24K 0.01%
230
– –
BLK icon
109
Blackrock
BLK
$163B
$24K 0.01%
29
+3
+12% +$2.69K
IHI icon
110
iShares US Medical Devices ETF
IHI
$3.02B
$23K 0.01%
360
– –
ARKK icon
111
ARK Innovation ETF
ARKK
$5.9B
$22K 0.01%
200
– –
IDU icon
112
iShares US Utilities ETF
IDU
$1.41B
$22K 0.01%
277
– –
LCID icon
113
Lucid Motors
LCID
$2.45B
$22K 0.01%
88
+58
+193% +$13.4K
VOD icon
114
Vodafone
VOD
$35B
$22K 0.01%
1,431
– –
SDC
115
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$22K 0.01%
4,200
– –
ABBV icon
116
AbbVie
ABBV
$457B
$21K 0.01%
192
+1
+0.5% +$114
ADP icon
117
Automatic Data Processing
ADP
$100B
$21K 0.01%
103
+1
+1% +$206
AI icon
118
C3.ai
AI
$1.28B
$21K 0.01%
452
– –
BANF icon
119
BancFirst
BANF
$3.94B
$21K 0.01%
355
– –
DG icon
120
Dollar General
DG
$26B
$21K 0.01%
100
– –
RCL icon
121
Royal Caribbean
RCL
$78.8B
$21K 0.01%
240
– –
UNH icon
122
UnitedHealth
UNH
$381B
$21K 0.01%
53
+8
+18% +$3.31K
ARCC icon
123
Ares Capital
ARCC
$13.5B
$20K ﹤0.01%
1,000
– –
FIVE icon
124
Five Below
FIVE
$11.2B
$20K ﹤0.01%
113
– –
GS icon
125
Goldman Sachs
GS
$313B
$20K ﹤0.01%
53
+3
+6% +$1.17K
3 4
5
6 7

Similar funds

MWM
Minot Wealth Management Westwood, Massachusetts $389M AUM 3.39% 1-Year Est. Return
BWM
BT Wealth Management Atlanta, Georgia $356M AUM 9.63% 1-Year Est. Return
FPS
Fieldpoint Private Securities Greenwich, Connecticut $344M AUM 7.21% 1-Year Est. Return
IC
Intersect Capital San Ramon, California $331M AUM 6.79% 1-Year Est. Return
TF
TRH Financial North Liberty, Iowa $297M AUM 7.9% 1-Year Est. Return
RIM
Reynolds Investment Management Greenville, South Carolina $281M AUM
PPW
Pinnacle Private Wealth Andover, Massachusetts $256M AUM
HA
HYA Advisors Springfield, Missouri $255M AUM 7.11% 1-Year Est. Return

Corbenic Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Corbenic Partners held 312 positions worth $412M, up 8.1% from $382M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Corbenic Partners deployed $30M of net new capital in Q3 2021, opening 49 new positions and adding to 64 existing holdings. Its largest new stake was Moderna: 64 shares worth $25K.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Pfizer, an estimated $288K trimmed.

  • Corbenic Partners's largest Q3 2021 buy was Moderna: 64 shares worth $25K.
  • Corbenic Partners added most to iShares Core Dividend Growth ETF in Q3 2021, an estimated $5.61M increase.
  • Corbenic Partners's biggest Q3 2021 reduction was Pfizer, cutting an estimated $288K.
  • Corbenic Partners fully exited Global X MSCI Greece ETF in Q3 2021, selling an estimated $85K.
  • Corbenic Partners's ten largest holdings make up 68% of its $412M portfolio in Q3 2021.
  • Corbenic Partners opened 49 new positions and closed 22 in Q3 2021.
  • Corbenic Partners's portfolio value rose 8.1% quarter-over-quarter to $412M.

Based on Corbenic Partners's 13F filing for Q3 2021, filed 13 Oct 2021.